 | | BFI | | Name: | 2[4-BROMO-2-FLUOROPHENYL)METHYL]-6-FLUOROSPIRO[ISOQUINOLINE-4-(1H),3'-PYRROLIDINE]-1,2',3,5'(2H)-TETRONE | | Formula: | C19 H11 Br F2 N2 O4 | | SMILES: | Brc1ccc(c(F)c1)CN4C(=O)c2ccc(F)cc2C3(C(=O)NC(=O)C3)C4=O | | InChi: | InChI=1S/C19H11BrF2N2O4/c20-10-2-1-9(14(22)5-10)8-24-16(26)12-4-3-11(21)6-13(12)19(18(24)28)7-15(25)23-17(19)27/h1-6H,7-8H2,(H,23,25,27)/t19-/m1/s1 | | Synonyms: | MINALRESTAT | | Definition date: | 2003-07-07 | | Last modified: | 2020-06-17 | | Identifier: | (4R)-2-(4-bromo-2-fluorobenzyl)-6-fluoro-1H,2'H,5'H-spiro[isoquinoline-4,3'-pyrrolidine]-1,2',3,5'(2H)-tetrone |
|
 | | SRY | | Name: | STREPTOMYCIN | | Formula: | C21 H39 N7 O12 | | SMILES: | O=CC3(O)C(OC1OC(C(O)C(O)C1NC)CO)C(OC2C(NC(=[N@H])N)C(O)C(NC(=[N@H])N)C(O)C2O)OC3C | | InChi: | InChI=1S/C21H39N7O12/c1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35/h4-18,26,29,31-36H,3H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/t5-,6-,7+,8-,9-,10-,11+,12-,13-,14+,15+,16-,17-,18-,21+/m0/s1 | | Synonyms: | STREPTOMYCIN A | | Definition date: | 2000-08-25 | | Last modified: | 2020-06-17 | | Identifier: | N,N'''-[(1R,2R,3S,4R,5R,6S)-4-({5-deoxy-2-O-[2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl]-3-C-formyl-alpha-L-lyxofuranosyl}oxy)-2,5,6-trihydroxycyclohexane-1,3-diyl]diguanidine |
|
 | | BFT | | Name: | S-BENZOYLTHIAMINE O-MONOPHOSPHATE | | Formula: | C19 H25 N4 O6 P S | | SMILES: | O=P(O)(O)OCCC(SC(=O)c1ccccc1)C(N(C=O)Cc2cnc(nc2N)C)C | | InChi: | InChI=1S/C19H25N4O6PS/c1-13(23(12-24)11-16-10-21-14(2)22-18(16)20)17(8-9-29-30(26,27)28)31-19(25)15-6-4-3-5-7-15/h3-7,10,12-13,17H,8-9,11H2,1-2H3,(H2,20,21,22)(H2,26,27,28)/t13-,17+/m0/s1 | | Synonyms: | BENFOTIAMINE | | Definition date: | 2006-07-20 | | Last modified: | 2020-06-17 | | Identifier: | 2-{[(4-amino-2-methylpyrimidin-5-yl)methyl](formyl)amino}-1,2,4-trideoxy-3-S-(phenylcarbonyl)-5-O-phosphono-3-thio-D-erythro-pentitol |
|
 | | BFZ | | Name: | 7-BROMO-1-[2-(DIETHYLAMINO)ETHYL]-5-(2-FLUOROPHENYL)-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE | | Formula: | C21 H23 Br F N3 O | | SMILES: | Fc3ccccc3C2=NCC(=O)N(c1c2cc(Br)cc1)CCN(CC)CC | | InChi: | InChI=1S/C21H23BrFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3 | | Synonyms: | BROMOFLURAZEPAM | | Definition date: | 2011-11-24 | | Last modified: | 2020-06-17 | | Release date: | 2012-10-12 | | Identifier: | 7-bromo-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
|
 | | SSD | | Name: | 1,4-DIDEOXY-1,4-[[2R,3R)-2,4-DIHYDROXY-3-(SULFOXY)BUTYL]EPISULFONIUMYLIDENE]-D-ARABINITOL INNER SALT | | Formula: | C9 H18 O9 S2 | | SMILES: | [O-]S([O-])([O-])OC(CO)C(O)C[S+]1C(CO)C(O)C(O)C1 | | InChi: | InChI=1S/C9H20O9S2/c10-1-7(18-20(15,16)17)5(12)3-19-4-6(13)9(14)8(19)2-11/h5-14H,1-4H2,(H2-,15,16,17)/p-2/t5-,6+,7+,8+,9-,19+/m0/s1 | | Synonyms: | DIASTEREOMER OF SALACINOL | | Definition date: | 2004-06-22 | | Last modified: | 2020-06-17 | | Identifier: | ({[(1R,2R)-3-[(2R,3S,4S)-3,4-dihydroxy-2-(hydroxymethyl)tetrahydrothiophenium-1-yl]-2-hydroxy-1-(hydroxymethyl)propyl]oxy}-lambda~4~-sulfanetriyl)trioxidanide (non-preferred name) |
|
 | | SSI | | Name: | [(3S)-4-hydroxy-3-{[(4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]amino}butyl]phosphonic acid | | Formula: | C11 H17 N4 O5 P | | SMILES: | O=P(O)(O)CCC(NCc2c1N=CNC(=O)c1nc2)CO | | InChi: | InChI=1S/C11H17N4O5P/c16-5-8(1-2-21(18,19)20)12-3-7-4-13-10-9(7)14-6-15-11(10)17/h4,6,8,12-13,16H,1-3,5H2,(H,14,15,17)(H2,18,19,20)/t8-/m0/s1 | | Synonyms: | S-SerMe-ImmH phosphonate | | Definition date: | 2010-09-27 | | Last modified: | 2020-06-17 | | Identifier: | [(3S)-4-hydroxy-3-{[(4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]amino}butyl]phosphonic acid |
|
 | | SSR | | Name: | 2-(3-fluoro-2-methylbenzyl)-4-methyl-1-phenyl-3-(piperazin-1-ylcarbonyl)-1H-indol-5-ol | | Formula: | C28 H28 F N3 O2 | | SMILES: | O=C(c3c1c(c(O)ccc1n(c2ccccc2)c3Cc4cccc(F)c4C)C)N5CCNCC5 | | InChi: | InChI=1S/C28H28FN3O2/c1-18-20(7-6-10-22(18)29)17-24-27(28(34)31-15-13-30-14-16-31)26-19(2)25(33)12-11-23(26)32(24)21-8-4-3-5-9-21/h3-12,30,33H,13-17H2,1-2H3 | | Synonyms: | [2-(3-Fluoro-2-methyl-benzyl)-5-hydroxy-4-methyl-1-phenyl-1H-indol-3-yl]-piperazin-1-yl-methanone | | Definition date: | 2010-09-01 | | Last modified: | 2020-06-17 | | Identifier: | [2-(3-fluoro-2-methylbenzyl)-5-hydroxy-4-methyl-1-phenyl-1H-indol-3-yl](piperazin-1-yl)methanone |
|
 | | SSU | | Name: | URIDINE-5'-PHOSPHOROTHIOATE | | Formula: | C9 H13 N2 O8 P S | | SMILES: | O=C1NC(=O)N(C=C1)C2OC(C(O)C2O)COP(=S)(O)O | | InChi: | InChI=1S/C9H13N2O8PS/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(19-8)3-18-20(16,17)21/h1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,21)/t4-,6-,7-,8-/m1/s1 | | Synonyms: | SP-SULFUR-SUBSTITUTED URIDINE | | Definition date: | 2003-04-09 | | Last modified: | 2020-06-17 | | Identifier: | 5'-O-thiophosphonouridine |
|
 | | BH7 | | Name: | E-AMINO BIOTINYL CAPROIC ACID | | Formula: | C16 H27 N3 O4 S | | SMILES: | O=C1NC2C(SCC2N1)CCCCC(=O)NCCCCCC(=O)O | | InChi: | InChI=1S/C16H27N3O4S/c20-13(17-9-5-1-2-8-14(21)22)7-4-3-6-12-15-11(10-24-12)18-16(23)19-15/h11-12,15H,1-10H2,(H,17,20)(H,21,22)(H2,18,19,23)/t11-,12-,15-/m0/s1 | | Synonyms: | 6-[5-(2-OXO-HEXAHYDRO-THIENO[3,4-D]IMIDAZOL-4-YL)-PENTANOYLAMINO]-HEXANOIC ACID | | Definition date: | 2002-04-15 | | Last modified: | 2020-06-17 | | Identifier: | 6-({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}amino)hexanoic acid |
|
 | | BHE | | Name: | octyl 2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-galactopyranoside | | Formula: | C20 H38 O10 | | SMILES: | O(CCCCCCCC)C2OC(C(O)C(O)C2OC1OC(C)C(O)C(O)C1O)CO | | InChi: | InChI=1S/C20H38O10/c1-3-4-5-6-7-8-9-27-20-18(16(25)14(23)12(10-21)29-20)30-19-17(26)15(24)13(22)11(2)28-19/h11-26H,3-10H2,1-2H3/t11-,12+,13+,14-,15+,16-,17-,18+,19-,20+/m0/s1 | | Synonyms: | H-antigen acceptor | | Definition date: | 2008-01-04 | | Last modified: | 2020-06-17 | | Identifier: | octyl 2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-galactopyranoside |
|
 | | BHF | | Name: | 2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE | | Formula: | C19 H12 O2 | | SMILES: | O=C1c4c(OC(=C1)c2ccccc2)c3ccccc3cc4 | | InChi: | InChI=1S/C19H12O2/c20-17-12-18(14-7-2-1-3-8-14)21-19-15-9-5-4-6-13(15)10-11-16(17)19/h1-12H | | Synonyms: | 7,8-BENZOFLAVONE | | Definition date: | 2006-06-30 | | Last modified: | 2020-06-17 | | Identifier: | 2-phenyl-4H-benzo[h]chromen-4-one |
|
 | | STI | | Name: | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE | | Formula: | C29 H31 N7 O | | SMILES: | O=C(Nc3ccc(c(Nc2nc(c1cccnc1)ccn2)c3)C)c4ccc(cc4)CN5CCN(CC5)C | | InChi: | InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34) | | Synonyms: | STI-571 | | Definition date: | 2001-04-11 | | Last modified: | 2020-06-17 | | Identifier: | 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide |
|
 | | BHN | | Name: | 2-[2-[carboxymethyl-[(2-hydroxyphenyl)methyl]amino]ethyl-[(2-hydroxyphenyl)methyl]amino]ethanoic acid | | Formula: | C20 H24 N2 O6 | | SMILES: | O=C(O)CN(Cc1ccccc1O)CCN(Cc2ccccc2O)CC(=O)O | | InChi: | InChI=1S/C20H24N2O6/c23-17-7-3-1-5-15(17)11-21(13-19(25)26)9-10-22(14-20(27)28)12-16-6-2-4-8-18(16)24/h1-8,23-24H,9-14H2,(H,25,26)(H,27,28) | | Synonyms: | N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid | | Definition date: | 2010-05-26 | | Last modified: | 2020-06-17 | | Identifier: | 2,2'-{ethane-1,2-diylbis[(2-hydroxybenzyl)imino]}diacetic acid (non-preferred name) |
|
 | | STX | | Name: | 1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE | | Formula: | C9 H15 N3 O2 | | SMILES: | O=C(c1nnc(o1)C(C)(C)C)CNC | | InChi: | InChI=1S/C9H15N3O2/c1-9(2,3)8-12-11-7(14-8)6(13)5-10-4/h10H,5H2,1-4H3 | | Synonyms: | 2-SARCOSINYL-5-TERT-BUTYL-[1,3,4]-OXADIAZOLE | | Definition date: | 2005-04-25 | | Last modified: | 2020-06-17 | | Identifier: | 1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-2-(methylamino)ethanone |
|
 | | SU2 | | Name: | 3-[4-(1-FORMYLPIPERAZIN-4-YL)-BENZYLIDENYL]-2-INDOLINONE | | Formula: | C20 H21 N3 O2 | | SMILES: | O=C2Nc1ccccc1C2Cc3ccc(cc3)N4CCN(C=O)CC4 | | InChi: | InChI=1S/C20H21N3O2/c24-14-22-9-11-23(12-10-22)16-7-5-15(6-8-16)13-18-17-3-1-2-4-19(17)21-20(18)25/h1-8,14,18H,9-13H2,(H,21,25) | | Synonyms: | SU4984 | | Definition date: | 1999-07-08 | | Last modified: | 2020-06-17 | | Identifier: | 4-(4-{[(3R)-2-oxo-2,3-dihydro-1H-indol-3-yl]methyl}phenyl)piperazine-1-carbaldehyde |
|
 | | BI1 | | Name: | 3-{1-[3-(DIMETHYLAMINO)PROPYL]-1H-INDOL-3-YL}-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE | | Formula: | C25 H24 N4 O2 | | SMILES: | O=C5C(c2c1ccccc1nc2)=C(c4c3ccccc3n(c4)CCCN(C)C)C(=O)N5 | | InChi: | InChI=1S/C25H24N4O2/c1-28(2)12-7-13-29-15-19(17-9-4-6-11-21(17)29)23-22(24(30)27-25(23)31)18-14-26-20-10-5-3-8-16(18)20/h3-6,8-11,14-15,26H,7,12-13H2,1-2H3,(H,27,30,31) | | Synonyms: | RBT205 INHIBITOR | | Definition date: | 2003-12-16 | | Last modified: | 2020-06-17 | | Identifier: | 3-{1-[3-(dimethylamino)propyl]-1H-indol-3-yl}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione |
|
 | | SU4 | | Name: | N-cyclopropyl-4-oxidanyl-N-[(2R)-2-oxidanyl-2-phenyl-propyl]benzenesulfonamide | | Formula: | C18 H21 N O4 S | | SMILES: | O=S(=O)(N(CC(O)(c1ccccc1)C)C2CC2)c3ccc(O)cc3 | | InChi: | InChI=1S/C18H21NO4S/c1-18(21,14-5-3-2-4-6-14)13-19(15-7-8-15)24(22,23)17-11-9-16(20)10-12-17/h2-6,9-12,15,20-21H,7-8,13H2,1H3/t18-/m0/s1 | | Synonyms: | HYDROXYBENZENESULFONAMIDE | | Definition date: | 2011-06-06 | | Last modified: | 2020-06-17 | | Identifier: | N-cyclopropyl-4-hydroxy-N-[(2R)-2-hydroxy-2-phenylpropyl]benzenesulfonamide |
|
 | | BI3 | | Name: | 3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE | | Formula: | C23 H20 N4 O2 | | SMILES: | O=C5C(c2c1ccccc1nc2)=C(c4c3ccccc3n(c4)CCCN)C(=O)N5 | | InChi: | InChI=1S/C23H20N4O2/c24-10-5-11-27-13-17(15-7-2-4-9-19(15)27)21-20(22(28)26-23(21)29)16-12-25-18-8-3-1-6-14(16)18/h1-4,6-9,12-13,25H,5,10-11,24H2,(H,26,28,29) | | Synonyms: | INHIBITOR OF 3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1 | | Definition date: | 2003-12-16 | | Last modified: | 2020-06-17 | | Identifier: | 3-[1-(3-aminopropyl)-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione |
|
 | | SU6 | | Name: | 3-{2,4-dimethyl-5-[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid | | Formula: | C18 H18 N2 O3 | | SMILES: | O=C(O)CCc1c(c(nc1C)/C=C3/c2ccccc2NC3=O)C | | InChi: | InChI=1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9- | | Synonyms: | SU6668 | | Definition date: | 2013-04-02 | | Last modified: | 2020-06-17 | | Release date: | 2013-06-19 | | Identifier: | 3-{2,4-dimethyl-5-[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid |
|
 | | SUE | | Name: | (1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-di
oxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadec
ino[11,12-b]quinoxaline-8-carboxamide | | Formula: | C38 H50 N6 O9 S | | SMILES: | O=S(=O)(NC(=O)C6(NC(=O)C1N2C(=O)C(NC(=O)OC5C(CCCCCc3nc4c(nc3OC(C1)C2)cc(OC)cc4)C5)C(C)(C)C)CC6/C=C)C7CC7 | | InChi: | InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1 | | Synonyms: | Grazoprevir, MK-5172 | | Definition date: | 2011-08-04 | | Last modified: | 2020-06-17 | | Release date: | 2012-09-14 | | Identifier: | (1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide |
|
 | | BID | | Name: | BISTRAMIDE A | | Formula: | C40 H68 N2 O8 | | SMILES: | O=C(/C=C/C)CC1OC(C(C)CC1)CC(=O)NCC(O)C(C(=O)NCCCC3OC2(OC(CCC2)CCC(C=C(/C)C(O)C)C)CCC3C)C | | InChi: | InChI=1S/C40H68N2O8/c1-8-11-32(44)23-34-17-15-27(3)37(48-34)24-38(46)42-25-35(45)30(6)39(47)41-21-10-13-36-28(4)18-20-40(50-36)19-9-12-33(49-40)16-14-26(2)22-29(5)31(7)43/h8,11,22,26-28,30-31,33-37,43,45H,9-10,12-21,23-25H2,1-7H3,(H,41,47)(H,42,46)/b11-8+,29-22+/t26-,27-,28-,30-,31-,33-,34+,35-,36+,37-,40-/m0/s1 | | Synonyms: | (2S,3R)-3-HYDROXY-N-(3-{(2R,3S,6S,8S)-8-[(3S,4E,6S)-6-HYDROXY-3,5-DIMETHYLHEPT-4-EN-1-YL]-3-METHYL-1,7-DIOXASPIRO[5.5]U
NDEC-2-YL}PROPYL)-2-METHYL-4-[({(2S,3S,6R)-3-METHYL-6-[(3E)-2-OXOPENT-3-EN-1-YL]TETRAHYDRO-2H-PYRAN-2-YL}ACETYL)AMINO]BU
TANAMIDE | | Definition date: | 2006-02-09 | | Last modified: | 2020-06-17 | | Identifier: | (2S,3R)-3-hydroxy-N-(3-{(2R,3S,6S,8S)-8-[(3S,4E,6S)-6-hydroxy-3,5-dimethylhept-4-en-1-yl]-3-methyl-1,7-dioxaspiro[5.5]undec-2-yl}propyl)-2-methyl-4-[({(2S,3S,6R)-3-methyl-6-[(3E)-2-oxopent-3-en-1-yl]tetrahydro-2H-pyran-2-yl}acetyl)amino]butanamide |
|
 | | SUG | | Name: | N~2~-(3-CARBOXYPROPANOYL)-L-ARGININE | | Formula: | C10 H18 N4 O5 | | SMILES: | O=C(NC(C(=O)O)CCCNC(=[N@H])N)CCC(=O)O | | InChi: | InChI=1S/C10H18N4O5/c11-10(12)13-5-1-2-6(9(18)19)14-7(15)3-4-8(16)17/h6H,1-5H2,(H,14,15)(H,16,17)(H,18,19)(H4,11,12,13)/t6-/m0/s1 | | Synonyms: | N~2~-SUCCINYLARGININE | | Definition date: | 2005-02-04 | | Last modified: | 2020-06-17 | | Identifier: | N~2~-(3-carboxypropanoyl)-L-arginine |
|
 | | BIH | | Name: | NAPHTHALENE-2,6-DISULFONIC ACID | | Formula: | C10 H8 O6 S2 | | SMILES: | O=S(=O)(O)c1ccc2c(c1)ccc(c2)S(=O)(=O)O | | InChi: | InChI=1S/C10H8O6S2/c11-17(12,13)9-3-1-7-5-10(18(14,15)16)4-2-8(7)6-9/h1-6H,(H,11,12,13)(H,14,15,16) | | Synonyms: | 2,6-NAPHTHALENEDISULFONIC ACID | | Definition date: | 2004-08-11 | | Last modified: | 2020-06-17 | | Identifier: | naphthalene-2,6-disulfonic acid |
|
 | | SUN | | Name: | O-[(R)-(DIMETHYLAMINO)(ETHOXY)PHOSPHORYL]-L-SERINE | | Formula: | C7 H17 N2 O5 P | | SMILES: | O=P(OCC)(OCC(N)C(=O)O)N(C)C | | InChi: | InChI=1S/C7H17N2O5P/c1-4-13-15(12,9(2)3)14-5-6(8)7(10)11/h6H,4-5,8H2,1-3H3,(H,10,11)/t6-,15+/m0/s1 | | Synonyms: | TABUN CONJUGATED SERINE | | Definition date: | 2007-01-25 | | Last modified: | 2020-06-17 | | Identifier: | O-[(R)-(dimethylamino)(ethoxy)phosphoryl]-L-serine |
|
 | | BIK | | Name: | 3,7-DIHYDROXY-2-NAPHTHOIC ACID | | Formula: | C11 H8 O4 | | SMILES: | O=C(O)c2cc1c(ccc(O)c1)cc2O | | InChi: | InChI=1S/C11H8O4/c12-8-2-1-6-5-10(13)9(11(14)15)4-7(6)3-8/h1-5,12-13H,(H,14,15) | | Synonyms: | 3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID | | Definition date: | 2004-08-11 | | Last modified: | 2020-06-17 | | Identifier: | 3,7-dihydroxynaphthalene-2-carboxylic acid |
|
